Selected Grants
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis
ResearchAdvisor · Awarded by National Institutes of Health · 2020 - 2025Clinical Pharmacokinetics and Safety Trials in Down Syndrome
Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025PTN 2.0 TO 6 Down Syndrome Extension
ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025PTN 2.0 TO 6 Down Syndrome Extension
Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025Identifying Pharmacogenomic Predictors of Methotrexate Response and Metabolite Biotransformation in JIA
ResearchPrincipal Investigator · Awarded by Cincinnati Children's Hospital Medical Center · 2017 - 2023PTN 2.0- TO 3 - Option 3 - BPCA Concept Development and Clinical Trial Readiness Support
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022HCQ Pharmacokinetics in Pediatric Lupus
ResearchMentor · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2020External Relationships
- American College of Rheumatology
- Canadian Arthritis Society
- Childhood Arthritis and Rheumatology Research Alliance
- Doris Duke Charitable Foundation
- Food and Drug Administration
- PCORI
- The Duke Endowment
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.